Basal Forebrain Cholinergic Neurons in Down Syndrome

Basal Forebrain Cholinergic Neurons in Down Syndrome

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Basal Forebrain Cholinergic Neurons in Down Syndrome</th>
</tr>
<tr>
<td class="label"><strong>Category</strong></td>
<td>Cholinergic System</td>
</tr>
<tr>
<td class="label"><strong>Location</strong></td>
<td>Basal nucleus of Meynert, medial septum, diagonal band</td>
</tr>
<tr>
<td class="label"><strong>Cell Type</strong></td>
<td>Cholinergic projection neurons</td>
</tr>
<tr>
<td class="label"><strong>Neurotransmitter</strong></td>
<td>Acetylcholine</td>
</tr>
<tr>
<td class="label"><strong>Chromosome</strong></td>
<td>Trisomy 21 (APP gene on chr 21)</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000108](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000108](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Target Region</td>
<td>Function</td>
</tr>
<tr>
<td class="labe

Basal Forebrain Cholinergic Neurons in Down Syndrome

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Basal Forebrain Cholinergic Neurons in Down Syndrome</th>
</tr>
<tr>
<td class="label"><strong>Category</strong></td>
<td>Cholinergic System</td>
</tr>
<tr>
<td class="label"><strong>Location</strong></td>
<td>Basal nucleus of Meynert, medial septum, diagonal band</td>
</tr>
<tr>
<td class="label"><strong>Cell Type</strong></td>
<td>Cholinergic projection neurons</td>
</tr>
<tr>
<td class="label"><strong>Neurotransmitter</strong></td>
<td>Acetylcholine</td>
</tr>
<tr>
<td class="label"><strong>Chromosome</strong></td>
<td>Trisomy 21 (APP gene on chr 21)</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000108](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000108](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Target Region</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>Attention, arousal, perception</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Memory consolidation, spatial navigation</td>
</tr>
<tr>
<td class="label">Amygdala</td>
<td>Emotional memory processing</td>
</tr>
<tr>
<td class="label">Olfactory bulb</td>
<td>Olfactory processing</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Change</td>
</tr>
<tr>
<td class="label">ChAT</td>
<td>Reduced</td>
</tr>
<tr>
<td class="label">AChE</td>
<td>Altered</td>
</tr>
<tr>
<td class="label">VAChT</td>
<td>Reduced</td>
</tr>
<tr>
<td class="label">p75NTR</td>
<td>Increased</td>
</tr>
</table>

Introduction

Down syndrome (DS), caused by trisomy 21, is the most common chromosomal disorder and confers a significantly increased risk for early-onset Alzheimer's disease (AD). Basal forebrain cholinergic neurons (BFCNs) are particularly vulnerable in both conditions, representing a key intersection between developmental and degenerative processes.

Overview

<!-- taxonomy-enrichment -->

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: cholinergic neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000108)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)
• [OBO Foundry (CL:0000108)](http://purl.obolibrary.org/obo/CL_0000108)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000108)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000108)
• [OBO Foundry (CL:0000108)](http://purl.obolibrary.org/obo/CL_0000108)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Neuroanatomy

The basal forebrain cholinergic system comprises several interconnected nuclei:

• Nucleus Basalis of Meynert (NBM): Primary source of cortical cholinergic innervation
• Medial Septum (MS): Hippocampal cholinergic projections
• Vertical Diagonal Band (VDB): Limbic system connections
• Horizontal Diagonal Band (HDB): Olfactory and cortical projections

Projection Patterns

Role in Down Syndrome

APP Overexpression

The amyloid precursor protein (APP) gene is located on chromosome 21, leading to triplication and overexpression in DS:

• APP copy number: 3 copies (vs 2 in euploid)
• Amyloid-beta production: Increased by 50%
• Early deposition: Detectable by age 20-30
• Amyloid plaques: Diffuse, widespread distribution

Cholinergic Vulnerability

BFCNs in DS show early vulnerability:

• Reduced choline acetyltransferase (ChAT) activity
• Decreased acetylcholine release
• Neuronal loss by age 40-50
• Correlation with cognitive decline

Alzheimer-Type Changes

Individuals with DS develop AD-type neuropathology:

• Amyloid plaques: Widespread, early onset
• Neurofibrillary tangles: Temporal progression
• Neuronal loss: Basal forebrain region
• Early onset AD: By age 55-60 in >50%

Molecular Mechanisms

APP Processing

APP is processed through two pathways:

In DS, the amyloidogenic pathway is favored due to increased APP expression.

Cholinergic Dysfunction

Key changes in BFCNs:

Therapeutic Implications

Current Approaches

• Acetylcholinesterase inhibitors: Modest symptomatic benefit
• Cholinergic agonists: Investigational
• Amyloid-targeting: Disease modification attempts

Emerging Strategies

• Neuroprotective agents: Support cholinergic neurons
• Gene therapy: NGF delivery approaches
• Stem cell approaches: Cell replacement strategies

Research Models

• iPSC models: DS cholinergic neurons
• Animal models: Ts65Dn mice
• Postmortem studies: Human brain tissue

External Links

• [Down Syndrome - NIH](https://www.ninds.nih.gov/health-information/disorders/down-syndrome)
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/)
• [Allen Brain Atlas - Basal Forebrain](https://human.brain-map.org)

Down Syndrome Cholinergic Degeneration

Pathological Features

• Early cholinergic neuron loss
• Reduced ChAT activity
• Impaired ACh release

Mechanisms

• APP/Abeta toxicity
• Oxidative stress
• Excitotoxicity
• [Neuroinflammation](/mechanisms/neuroinflammation)

Therapeutic Strategies

• Cholinergic augmentation
• Neurotrophic factors
• Antioxidant therapy

References

[^3

See Also

• [Alibaba Tongyi Qianwen-Bio (Chinese Biomedical LLM)](/wiki/ai-tool-alibaba-tongyi-qianwen-bio) — cell_type_involved_in